康希诺生物(06185)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06185 康希诺生物

未开盘 12-11 16:08:09

22.850

-0.400

-1.72%

最高23.500	最低22.350	成交量143.58万
今开23.650	昨收23.250	日振幅4.95%
总市值56.54亿	流通市值30.32亿	总股本2.47亿
成交额3,261万	换手率1.08%	流通股本1.33亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06185","market":"HK","secType":"STK","nameCN":"康希诺生物","latestPrice":22.85,"timestamp":1702282089021,"preClose":23.25,"halted":0,"volume":1435800,"delay":0,"floatShares":132670900,"shares":247449899,"eps":-3.9932947,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.4,"latestTime":"12-11 16:08:09","open":23.65,"high":23.5,"low":22.35,"amount":32613970,"amplitude":0.049462,"askPrice":23,"askSize":3000,"bidPrice":22.85,"bidSize":8600,"shortable":3,"etf":0,"ttmEps":-6.239474253678336,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1702344600000},"adr":0,"listingDate":1553702400000,"adjPreClose":23.25,"dividendRate":0.039522,"volumeRatio":0.8551429121766562,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688185","market":"SH","secType":"STK","nameCN":"康希诺","latestPrice":77.14,"timestamp":1702278000000,"preClose":76.67,"halted":0,"volume":2253410,"delay":0,"premium":"-72.70"}},"requestUrl":"/m/hq/s/06185","defaultTab":"news","newsList":[{"id":"2390333725","title":"康希诺： 相关专利为以前年度申请，并于近期取得授权","url":"https://stock-news.laohu8.com/highlight/detail?id=2390333725","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2390333725?lang=zh_cn&edition=full","pubTime":"2023-12-11 18:31","pubTimestamp":1702290702,"startTime":"0","endTime":"0","summary":"证券之星消息，康希诺12月11日在投资者关系平台上答复投资者关心的问题。投资者：尊敬的董秘你好，近日观察到上药康希诺公布了两项与幽门螺旋杆菌相关的专利，公开号分别为CN117186193A、CN117187222A，请问是否有关于幽门螺旋杆菌疫苗的研发立项计划？","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231211183145874d8c33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231211183145874d8c33&s=b","is_publish_highlight":false},{"id":"2390335172","title":"智通AH统计|12月11日","url":"https://stock-news.laohu8.com/highlight/detail?id=2390335172","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2390335172?lang=zh_cn&edition=full","pubTime":"2023-12-11 16:15","pubTimestamp":1702282505,"startTime":"0","endTime":"0","summary":"智通财经APP数据显示，截止12月11日收盘，东北电气、弘业期货、浙江世宝分列AH溢价率前三位，溢价率分别为1073.91%、922.56%、662.50%；药明康德、比亚迪股份、海尔智家分列AH溢价率末三位，溢价率分别为12.94%、14.60%、16.46%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1036204.html","is_publish_highlight":false},{"id":"2390804440","title":"康希诺12月8日获北向资金加仓46.34万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2390804440","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2390804440?lang=zh_cn&edition=full","pubTime":"2023-12-11 09:30","pubTimestamp":1702258235,"startTime":"0","endTime":"0","summary":"12月8日, 北向资金增持康希诺46.34万股，连续4日增持。截止当日收盘，沪股通共持有康希诺128.40万股，占流通股1.11%。沪股通增持金额前五个股分别为贵州茅台、药明康德、韦尔股份、传音控股、中国石化。康希诺近5个交易日下跌8.56%，沪股通累计增持54.75万股；近20个交易日下跌9.54%，沪股通累计增持1.74万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023121109382683ed39ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023121109382683ed39ba&s=b","is_publish_highlight":false},{"id":"2390809833","title":"智通港股通占比异动统计|12月11日","url":"https://stock-news.laohu8.com/highlight/detail?id=2390809833","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2390809833?lang=zh_cn&edition=full","pubTime":"2023-12-11 08:35","pubTimestamp":1702254947,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，根据2023年12月8日披露数据，南方恒生科技、微创医疗、盈富基金港股通持股占比增加值最大，分别增加2.04%、1.74%、1.37%；弘业期货、海通国际、美图公司港股通持股占比减少值最大，分别减少-1.35%、-0.54%、-0.53%。在最近有统计数据的5个交易日内，盈富基金、南方恒生科技、恒生中国企业港股通持股占比增加值最大，分别增加5.65%、5.45%、5.09%；融创中国、京城机电股份、凯莱英港股通持股占比减少值最大，分别减少-11.41%、-3.60%、-2.62%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1036028.html","is_publish_highlight":false},{"id":"2389883063","title":"智通港股空仓持单统计|12月8日","url":"https://stock-news.laohu8.com/highlight/detail?id=2389883063","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2389883063?lang=zh_cn&edition=full","pubTime":"2023-12-08 18:30","pubTimestamp":1702031403,"startTime":"0","endTime":"0","summary":"智通财经APP数据显示，截止12月1日，未平仓空单比位列前三位为药明康德、福莱特玻璃、长城汽车，空仓比分别为20.83%、20.26%、15.08%。未平仓空单比（绝对值）较上一次增加最多为九龙仓集团、浙江沪杭甬、零跑汽车，分别增加1.34%、1.29%、1.27%。智通机器人根据港交所数据，经过人工智能运算后自动生成，并不保证数据100%准确；以上涉及的空仓比增加值或减少值为绝对值数。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1035601.html","is_publish_highlight":false},{"id":"2389836511","title":"康希诺生物12月08日遭主力抛售258万元 环比增加975.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2389836511","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2389836511?lang=zh_cn&edition=full","pubTime":"2023-12-08 16:16","pubTimestamp":1702023402,"startTime":"0","endTime":"0","summary":"12月08日, 康希诺生物股价涨0.22%，报收23.25元，成交金额2862万元，换手率0.93%，振幅2.80%，量比0.72。康希诺生物今日主力资金净流出258万元，上一交易日主力净流出24万元，今日环比增加975.00%。该股近5个交易日下跌11.49%，主力资金累计净流出638万元；近20日主力资金累计净流出1100万元，其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023120816183483e26c62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023120816183483e26c62&s=b","is_publish_highlight":false},{"id":"2389002389","title":"北向资金12月7日净买入康希诺9.94万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2389002389","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2389002389?lang=zh_cn&edition=full","pubTime":"2023-12-08 09:30","pubTimestamp":1701999036,"startTime":"0","endTime":"0","summary":"12月7日, 北向资金增持康希诺9.94万股，连续3日增持。截止当日收盘，沪股通共持有康希诺82.06万股，占流通股0.71%。沪股通增持金额前五个股分别为贵州茅台、赛力斯、工商银行、农业银行、中微公司。康希诺近5个交易日下跌9.98%，沪股通累计减持0.58万股；近20个交易日下跌10.55%，沪股通累计减持32.16万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023120809394783e078c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023120809394783e078c3&s=b","is_publish_highlight":false},{"id":"2389093904","title":"智通港股通占比异动统计|12月7日","url":"https://stock-news.laohu8.com/highlight/detail?id=2389093904","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2389093904?lang=zh_cn&edition=full","pubTime":"2023-12-07 08:35","pubTimestamp":1701909350,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，根据2023年12月6日披露数据，昭衍新药、美图公司、浙江世宝港股通持股占比增加值最大，分别增加0.82%、0.68%、0.64%；凯莱英、恒生中国企业、弘业期货港股通持股占比减少值最大，分别减少-1.28%、-0.89%、-0.84%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1034708.html","is_publish_highlight":false},{"id":"2389087622","title":"康希诺(688185.SH)：青少年及成人用百白破加强疫苗启动I期临床试验并完成首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2389087622","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2389087622?lang=zh_cn&edition=full","pubTime":"2023-12-06 17:08","pubTimestamp":1701853710,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康希诺 公告，公司的吸附无细胞百(组分)白破联合疫苗于近日正式启动I期临床试验，并完成首例受试者入组。据悉，青少年及成人用Tdcp适用于6岁及以上人群，为青少年及成人的百白破加强疫苗，主要发达国家已将该疫苗纳入常规的疫苗接种计划，但国内并无获批的青少年及成人用百白破加强疫苗，该产品若成功上市，将填补国内市场空白。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1034377.html","is_publish_highlight":false},{"id":"2389069417","title":"康希诺前三季度亏损近10亿元 股价较最高点下跌近90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2389069417","media":"中国网财经","top":-1,"share":"https://www.laohu8.com/m/news/2389069417?lang=zh_cn&edition=full","pubTime":"2023-12-06 10:38","pubTimestamp":1701830280,"startTime":"0","endTime":"0","summary":"近年来，受新冠疫苗市场需求的影响，康希诺业绩波动较大。新冠疫情前的2018年和2019年，康希诺一直处于亏损状态。今年前三季度，康希诺实现营收1.76亿元，同比下滑75.17%；归属于上市公司股东的净利润亏损9.85亿元，同比下滑107.63%；扣非净利润亏损10.79亿元，同比下滑85.28%。今年前三季度，康希诺计提资产减值损失合计约7.87亿元，其中第三季度计提约7503万元，主要为存货跌价损失。亏损的康希诺，也需应对股价下跌压力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202312061043177a317339&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202312061043177a317339&s=b","is_publish_highlight":false},{"id":"2389772023","title":"智通港股通占比异动统计|12月6日","url":"https://stock-news.laohu8.com/highlight/detail?id=2389772023","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2389772023?lang=zh_cn&edition=full","pubTime":"2023-12-06 08:35","pubTimestamp":1701822951,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，根据2023年12月5日披露数据，南方恒生科技、盈富基金、香港科技探索港股通持股占比增加值最大，分别增加1.80%、1.70%、1.18%；京城机电股份、长城汽车、COSMOPOL INT'L港股通持股占比减少值最大，分别减少-0.74%、-0.53%、-0.34%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1033961.html","is_publish_highlight":false},{"id":"2389771915","title":"智通AH统计|12月5日","url":"https://stock-news.laohu8.com/highlight/detail?id=2389771915","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2389771915?lang=zh_cn&edition=full","pubTime":"2023-12-05 16:15","pubTimestamp":1701764106,"startTime":"0","endTime":"0","summary":"智通财经APP数据显示，截止12月5日收盘，东北电气、弘业期货、浙江世宝分列AH溢价率前三位，溢价率分别为1167.61%、869.57%、663.37%；药明康德、比亚迪股份、海尔智家分列AH溢价率末三位，溢价率分别为10.47%、13.18%、15.88%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1033538.html","is_publish_highlight":false},{"id":"2389979826","title":"康希诺CEO：公司预计到2025年将实现收支平衡","url":"https://stock-news.laohu8.com/highlight/detail?id=2389979826","media":"华尔街见闻","top":-1,"share":"https://www.laohu8.com/m/news/2389979826?lang=zh_cn&edition=full","pubTime":"2023-12-05 10:02","pubTimestamp":1701741722,"startTime":"0","endTime":"0","summary":"康希诺 CEO：公司预计到2025年将实现收支平衡。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231205100923822ec2cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231205100923822ec2cd&s=b","is_publish_highlight":false},{"id":"2389272769","title":"康希诺：十三价肺炎结合疫苗正开展新药上市申报前的各项准备工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2389272769","media":"界面","top":-1,"share":"https://www.laohu8.com/m/news/2389272769?lang=zh_cn&edition=full","pubTime":"2023-12-05 07:30","pubTimestamp":1701732649,"startTime":"0","endTime":"0","summary":"康希诺近期投资者关系活动记录表显示，公司的十三价肺炎结合疫苗正在开展新药上市申报前的各项准备工作，是公司最临近商业化的下一款产品；MCV4适应症人群的扩展临床试验也在推进中，以期将该款产品的商业价值发挥到最大。同时，公司在研产品管线丰富，涵盖预防脑膜炎球菌、肺炎、百白破、结核病、带状疱疹等多个临床需求量较大的疫苗品种，随着研发进度的加速推进，以期对经营结果的体现起到积极作用。公司海外业务布局以新兴市场、发展中国家为主，重点布局中东、东南亚、南美等地区。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023120507304978fff96c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023120507304978fff96c&s=b","is_publish_highlight":false},{"id":"2388789245","title":"康希诺生物12月04日遭主力抛售407万元 环比增加402.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2388789245","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2388789245?lang=zh_cn&edition=full","pubTime":"2023-12-04 16:15","pubTimestamp":1701677755,"startTime":"0","endTime":"0","summary":"12月04日, 康希诺生物股价跌4.60%，报收24.90元，成交金额6459万元，换手率1.90%，振幅9.77%，量比1.31。康希诺生物今日主力资金净流出407万元，上一交易日主力净流出81万元，今日环比增加402.47%。该股近5个交易日下跌5.85%，主力资金累计净流入147万元；近20日主力资金累计净流出621万元，其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231204161648822bac6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231204161648822bac6d&s=b","is_publish_highlight":false},{"id":"2388786257","title":"智通AH统计|12月4日","url":"https://stock-news.laohu8.com/highlight/detail?id=2388786257","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2388786257?lang=zh_cn&edition=full","pubTime":"2023-12-04 16:15","pubTimestamp":1701677705,"startTime":"0","endTime":"0","summary":"智通财经APP数据显示，截止12月4日收盘，东北电气、弘业期货、浙江世宝分列AH溢价率前三位，溢价率分别为1179.62%、846.91%、677.18%；比亚迪股份、海尔智家、紫金矿业分列AH溢价率末三位，溢价率分别为13.86%、17.55%、17.86%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1032903.html","is_publish_highlight":false},{"id":"2388855783","title":"康希诺生物(06185)下跌5.17%，报24.75元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2388855783","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2388855783?lang=zh_cn&edition=full","pubTime":"2023-12-04 15:21","pubTimestamp":1701674477,"startTime":"0","endTime":"0","summary":"12月4日，康希诺生物(06185)盘中下跌5.17%，截至15:21，报24.75元/股，成交5736.91万元。康希诺生物股份公司是一家专注于疫苗研发、生产和商业化的高科技生物制品企业，其主要产品包括新冠疫苗、四价流脑结合疫苗、二价流脑结合疫苗和重组埃博拉病毒病疫苗等。公司已在香港和上海两地上市，拥有全球创新的五大技术平台，已建立数十条产品研发管线，并在中国天津、上海以及墨西哥、巴基斯坦、马来西亚等国家建立了大规模现代化疫苗产业基地。截至2023年三季报，康希诺生物营业总收入1.76亿元、净利润-9.85亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2023/12/04152138660540.shtml","is_publish_highlight":false},{"id":"2388788018","title":"康希诺生物盘中异动 股价大跌5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2388788018","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2388788018?lang=zh_cn&edition=full","pubTime":"2023-12-04 15:16","pubTimestamp":1701674195,"startTime":"0","endTime":"0","summary":"2023年12月04日下午盘15时16分，康希诺生物股票出现异动，股价快速下跌5.37%。康希诺生物股票所在的生物技术行业中，整体跌幅为4.28%。消息层面，截至15时16分，康希诺生物股票正面舆情新闻比例9.09%。《康希诺：吸入用重组新冠病毒XBB.1.5变异株疫苗被纳入紧急使用》资讯为影响康希诺生物的重要信息。该信息摘要如下：康希诺12月3日公告，公司研发的吸入用重组新冠病毒XBB.1.5变异株疫苗经国家卫生健康委提出建议，国家药监局组织论证同意紧急使用。。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231204151635830a81ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231204151635830a81ce&s=b","is_publish_highlight":false},{"id":"2388203228","title":"康希诺生物(06185)：吸入用重组新冠病毒XBB.1.5变异株疫苗(5型腺病毒载体)被纳入紧急使用","url":"https://stock-news.laohu8.com/highlight/detail?id=2388203228","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2388203228?lang=zh_cn&edition=full","pubTime":"2023-12-03 18:10","pubTimestamp":1701598201,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康希诺生物(06185)发布公告，公司研发的吸入用重组新冠病毒XBB.1.5变异株疫苗(5型腺病毒载体)经中国国家卫生健康委员会提出建议，国家药品监督管理局组织论证同意紧急使用。公司的全球首款吸入用新冠疫苗克威莎®雾优®不仅可激发体液免疫及细胞免疫，还可以诱导黏膜免疫，有效实现三重综合保护，过程中毋须进行肌肉注射。吸入用新冠XBB.1.5变异株疫苗将助力免疫策略的更新及为民众提供更佳保护。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1032653.html","is_publish_highlight":false},{"id":"2387749474","title":"康希诺生物盘中异动 下午盘股价大涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2387749474","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2387749474?lang=zh_cn&edition=full","pubTime":"2023-11-30 13:50","pubTimestamp":1701323403,"startTime":"0","endTime":"0","summary":"2023年11月30日下午盘13时50分，康希诺生物股票出现异动，股价急速拉升5.16%。截至发稿，该股报27.500港元/股，成交量107.454万股，换手率0.81%，振幅7.07%。康希诺生物股票所在的生物技术行业中，整体跌幅为0.27%。其相关个股中，莲和医疗、和誉-B、君实生物涨幅较大，振幅较大的相关个股有博安生物、莲和医疗、和誉-B，振幅分别为18.19%、17.14%、16.67%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023113013500378ff72ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023113013500378ff72ca&s=b","is_publish_highlight":false}],"profile":{"websiteUrl":"http://www.cansinotech.com","stockEarnings":[{"period":"1week","weight":-0.0823},{"period":"1month","weight":-0.1751},{"period":"3month","weight":-0.0277},{"period":"6month","weight":-0.1537},{"period":"1year","weight":-0.7435},{"period":"ytd","weight":-0.6577}],"compareEarnings":[{"period":"1week","weight":-0.0267},{"period":"1month","weight":-0.0582},{"period":"3month","weight":-0.1012},{"period":"6month","weight":-0.1652},{"period":"1year","weight":-0.1859},{"period":"ytd","weight":-0.181}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康希诺生物股份公司是一家处于临床阶段的中国疫苗公司。该公司的产品包括埃博拉病毒疫苗Ad5-EBOV、脑膜炎球菌疫苗MCV2和MCV4、肺炎球菌疫苗PBPV和重组新型冠状病毒疫苗等。其产品主要应用于脑膜炎、百白破和肺炎领域。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.04767},{"month":2,"riseRate":0.75,"avgChangeRate":0.189602},{"month":3,"riseRate":0.25,"avgChangeRate":-0.017968},{"month":4,"riseRate":0.6,"avgChangeRate":0.062972},{"month":5,"riseRate":0.2,"avgChangeRate":-0.084834},{"month":6,"riseRate":0.6,"avgChangeRate":0.056507},{"month":7,"riseRate":0.6,"avgChangeRate":0.025366},{"month":8,"riseRate":0,"avgChangeRate":-0.212187},{"month":9,"riseRate":0.6,"avgChangeRate":-0.019121},{"month":10,"riseRate":0.6,"avgChangeRate":0.097338},{"month":11,"riseRate":0.8,"avgChangeRate":0.15426},{"month":12,"riseRate":0.6,"avgChangeRate":-0.055873}],"exchange":"SEHK","name":"康希诺生物","nameEN":"CANSINOBIO"},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.19.1","shortVersion":"4.19.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康希诺生物(06185)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康希诺生物(06185)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康希诺生物,06185,康希诺生物股票,康希诺生物股票老虎,康希诺生物股票老虎国际,康希诺生物行情,康希诺生物股票行情,康希诺生物股价,康希诺生物股市,康希诺生物股票价格,康希诺生物股票交易,康希诺生物股票购买,康希诺生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康希诺生物(06185)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康希诺生物(06185)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}